p.petrov
Submits third-party assay reports on material purchased directly. Based in Antalya.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.13%
n=10
Suppliers covered
8
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041474 | PT-141 (Bremelanotide) | QYB | QYB-2607-L4875 | VendorInvestigate | 2026-Q3 | 99.16 | 3.78 | 95.6 | Buyer-sourced | 0 | PASS |
| AX-2026-041586 | Liraglutide | QSC | QSC-2605-W7381 | Janoshik | 2026-Q3 | 98.85 | 6.00 | 90.7 | Buyer-sourced | 0 | PASS |
| AX-2026-042604 | Semaglutide | HJ | HJ-2608-C7002 | Janoshik | 2026-Q3 | 99.12 | 4.19 | 102.5 | Buyer-sourced | 0 | PASS |
| AX-2026-042345 | ARA-290 | Homopeptide | HOMO-2601-T3123 | Janoshik | 2026-Q2 | 99.51 | 4.25 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042038 | Epitalon | HYB | HYB-2603-U7133 | VendorInvestigate | 2026-Q2 | 99.86 | 6.83 | 95.7 | Buyer-sourced | 0 | FAIL |
| AX-2025-020270 | MGF | GGPeps | GGPE-2506-T1988 | VendorInvestigate | 2025-Q4 | 98.57 | 4.34 | 88.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020335 | Tirzepatide | GGPeps | GGPE-2412-M2779 | VendorInvestigate | 2025-Q2 | 98.40 | 4.77 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018424 | Semaglutide | WWB | WWB-2501-S2183 | Kestrel | 2025-Q1 | 99.50 | 4.11 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004917 | GHRP-2 | GGPeps | GGPE-2406-F1736 | Janoshik | 2024-Q4 | 99.14 | 6.04 | 92.5 | Buyer-sourced | 0 | PASS |
| AX-2024-005224 | Semax | WXT | WXT-2402-W2466 | PeptideMeter | 2024-Q2 | 98.55 | 7.03 | — | Buyer-sourced | 0 | PASS |